𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epstein-barr virus subtype distribution in angioimmunoblastic lymphadenopathy

✍ Scribed by Bettina Borisch; Massimo Caioni; Nina Hurwitz; Corina Dommann-Scherrer; B. Odermatt; Ernst Waelti; R. Hubert Hubert; Rainer Kraft; Jean Laissue


Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
679 KB
Volume
55
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Serum epstein–barr virus DNA load in pri
✍ Claudia C. Bauer; Stephan W. Aberle; Theresia Popow-Kraupp; Magdalena Kapitan; H 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Specific viral laboratory diagnosis of primary Epstein–Barr Virus (EBV) infection is usually based on antibody‐detection assays. During acute, lytic phase of infection, viral DNA can also be detected in serum. In the present study, the diagnostic utility of EBV DNA detection and quantit

Intracytoplasmic type a virus-like parti
✍ Mikihire Shamoto; Taizan Suchi 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 895 KB

Virus-like particles which seemed to be oncogenic have not been observed clinically in human neoplasms. However, we found some virus-like particles in the cytoplasm of a few proliferating cells in the lymph nodes of one patient with angioimmunoblastic lymphadenopathy. These were very similar to intr

Latency pattern of Epstein-Barr virus an
✍ Mikio Yoshioka; Hideaki Kikuta; Nobuhisa Ishiguro; Rika Endo; Kunihiko Kobayashi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Expression of different panels of latent gene transcripts is controlled by usage of three distinct Epstein‐Barr virus (EBV) nuclear antigen (EBNA) promoters (Wp, Cp, and Qp). EBV‐associated hemophagocytic syndrome, which is often a fatal disease and generally occurs after primary EBV in

Epstein-Barr virus-specific antibodies i
✍ Shinkura, R.; Yamamoto, N.; Koriyama, C.; Shinmura, Y.; Eizuru, Y.; Tokunaga, M. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

We examined Epstein-Barr virus (EBV)-specific antibodies in serum samples from 64 and 59 patients with EBV-positive and -negative gastric carcinomas, respectively, and 73 healthy controls using immunofluorescence assays. EBV capsid antigen (VCA) IgG and EBV-determined nuclear antigen (EBNA) IgG were